The Inherited Retinal Disease Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Inherited Retinal Disease Market?
The market for inherited retinal disease has seen significant expansion recently. The market size, previously $11.56 billion in 2024, is anticipated to increase to $12.58 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Inherited Retinal Disease Industry?
The Inherited Retinal Disease Global Market Report 2025 predicts the market size to be $17.42 billion in 2029. The forecast also estimates a compound annual growth rate (CAGR) of 8.5% for the same period.
Download Your Free Sample of the 2025 Inherited Retinal Disease Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Inherited Retinal Disease Market?
The key drivers in the inherited retinal disease market are:
•The increasing use of CRISPR technology
•Emergence of personalized treatments for patients
•Focus on regenerative medicine to treat retinal diseases
•Increased patient advocacy to promote quality of life for patients
Global Market Segmentation: Identifying Major Inherited Retinal Disease Industry Segments
The inherited retinal disease market covered in this report is segmented –
1) By Type: Diagnosis, Therapy
2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rode Dystrophy, Leber Congenital Amaurosis, Other Diseases
3) By Distribution Channel: Retail Sales, Direct Tender
4) By End Users: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users
Subsegments,
1) By Diagnosis: Genetic Testing (Genetic Screening), Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)), Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging
2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy (Gene Editing, Retinal Drugs), Photoreceptor Rescue Therapy
Pre-order the 2025 Inherited Retinal Disease Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Inherited Retinal Disease Market?
The key trends in the inherited retinal disease market are:
•Advancements in optogenetics technology are emerging trends.
•There is a significant shift towards the development of artificial retina implants.
•The expansion of digital health platforms is a noticeable trend.
•The use of artificial intelligence in disease modeling and treatment planning is an emerging trend.
Who Are the Top Competitors & Leading Players in the Inherited Retinal Disease Market?
Major players in the inherited retinal disease market are:
• Johnson & Johnson
• Novartis AG
• Astellas Pharma Inc.
• Biogen Inc.
• Vertex Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• Invitae Corporation
• Spark Therapeutics
• Aldeyra Therapeutics
• Regenxbio Inc.
• IVERIC bio
• MeiraGTx Limited
• Ocugen Inc.
• Coave Therapeutics
• Bionic Vision Technologies
• GenSight Biologics SA
• LKC Technologies Inc.
• Sparing Vision
• ProQR Therapeutics NV
• Endogena Therapeutics
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the inherited retinal disease market in 2024
